PharmaShots Connects Brands & Decision-Makers with Custom Media Solutions PharmaShots Provides Curated News & Insights for the Biopharma & Healthcare Industry PharmaShots is Empowering Decision Makers with Actionable Insights Amplify Your Brand with PharmaShots’ Expert Content Creation & Marketing Solutions PharmaShots Enables Brands to Strategically Connect with Their Target Audiences Deliver Your News to the Right Audience with PharmaShots Newswire CXO TALKS CXO TALKSCytek Biosciences on Redefining Flow Cytometry Excellence | PharmaShots CXO Talks CXO TALKSCXO Talks Podcast | Building Smarter Biotech: Venkat Nelabhotla, CEO of Vyome Holdings, on Driving Innovation Across the US–India Corridor CXO TALKSCXO Talks Podcast | The Road to Acquisition: Oncolytics’ CEO Jared Kelly on Clinical Data, IP & Pharma Partnerships CXO TALKSPharmaShots CXO Talks | Women’s History Month Special: A Conversation with Dr. Emanuela Offidani of Tris Pharma EXCLUSIVE INTERVIEW EXCLUSIVEOncolytics Biotech’s Next Chapter: Jared Kelly on Advancing Pelareorep Toward Approval EXCLUSIVEGona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare EXCLUSIVEExclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight EXCLUSIVEExclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind EXCLUSIVEExclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots EXCLUSIVEExclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEAdvancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEDecoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots LATEST NEWSStay up-to-date Meitheal Pharmaceuticals Reports US FDA Approval of High-Concentration Formulation of Yusimry (Biosimilar, Humira) 9 hours ago Vanda Pharmaceuticals Reports the P-III Trial Results on Hetlioz in Delayed Sleep-Wake Phase Disorder 10 hours ago Takeda Reports P-III (LATITUDE) Program Results on Zasocitinib for Plaque Psoriasis 12 hours ago Eli Lilly Reports P-III (TRIUMPH-2) Results on Retatrutide for Obesity and Type 2 Diabetes 13 hours ago Tolerance Bio and Tanabe Pharma Partner for MT-2990 in Deal With Up to $560M in Milestones 14 hours ago Egetis Therapeutics Reports the US FDA Approval of Emcitate for MCT8 Deficiency 15 hours ago Read More Your Daily Dose of Biopharma News & Insights Delivered to Your Inbox. Join the PharmaShots Family of 20000+ subscribers Subscribe Now
Meitheal Pharmaceuticals Reports US FDA Approval of High-Concentration Formulation of Yusimry (Biosimilar, Humira) 9 hours ago
Vanda Pharmaceuticals Reports the P-III Trial Results on Hetlioz in Delayed Sleep-Wake Phase Disorder 10 hours ago
Eli Lilly Reports P-III (TRIUMPH-2) Results on Retatrutide for Obesity and Type 2 Diabetes 13 hours ago
Tolerance Bio and Tanabe Pharma Partner for MT-2990 in Deal With Up to $560M in Milestones 14 hours ago
